dallas 8/11/2010 11:36:51 PM
News / Business

Top Penny Stock Gainers Today include ICOP, BOSC, RPRX

Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/

Active Penny Stocks in the News

PennyTrader.com presents a range of the hottest penny stocks on the OTC and OTCBB market today. In addition to daily hot stock alerts, PennyTrader.com‘s new penny stock alert service is fast becoming the premier stock alert list to be on.

Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/

ICOP Digital, Inc. (NASDAQ: ICOP) reached up 174.34% in morning trading to $3.10 with 1M shares traded. ICOP Digital, Inc. (NASDAQ: ICOP), an industry-leading company engaged in advancing digital surveillance technology solutions, today announced the receipt of an initial order for the ICOP Model 20/20®-W in-car video systems from the US Department of Homeland Security . Due to the security nature of the project, ICOP agreed not to release details of the project until the Department releases its own press release. The order will outfit just over one hundred (100) vehicles, and will include recording of mobile video/audio, wireless uploading, live streaming video capability, and ICOP's video management software.

For detailed quote and full article http://www.pennytrader.com/quotes/ICOP.php

B.O.S. Better Online Solutions Ltd. (Nasdaq: BOSC) reached up 26.97% in morning trading to $1.384 with 130K shares traded. B.O.S. Better Online Solutions Ltd. (the "Company", "BOS") (Nasdaq:BOSC), a leading Israeli provider of RFID and supply chain solutions to global enterprises, today reported its financial results for the second quarter, ended June 30, 2010.

For detailed quote and full article http://www.pennytrader.com/quotes/BOSC.php

Repros Therapeutics Inc. (NasdaqCM: RPRX) reached up 10.90% in morning trading to $.406 with 1M shares traded. Repros Therapeutics focuses on the development of oral small molecule drugs for major unmet medical needs that treat male and female reproductive disorders. Repros Therapeutics Inc. (NasdaqCM: RPRX) today announced the US Patent and Trademark office has issued U.S. Patent No. 7,759,360 for Androxal, the Companys lead program for the treatment of low testosterone in men.

For detailed quote and full article http://www.pennytrader.com/quotes/RPRX.php

Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/

About PennyTrader.com

PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks
in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report

 For complete disclosure information go to http://www.pennytrader.com/disclosure/

PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to http://www.pennytrader.com/disclaimer/